Related Experiment Video
Updated: Jun 23, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
[The unsolved problem of diabetes mellitus type 2 and associated complications]
M Morcos1, P Humpert, A Bierhaus
1Medizinische Klinik (Krehl-Klinik), Abteilung Innere Medizin 1 und Klinische Chemie, Universitätsklinikum Heidelberg, INF 410, 69120 Heidelberg, Deutschland. Michael.Morcos@med.uni-heidelberg.de
Abstract:
Type 2 diabetes and impaired glucose tolerance are an increasing burden not only for affected patients, but also for the whole health care system. The pathophysiology of diabetes and its late complications are far from being understood with hyperglycaemia being only the last sign of a long lasting and complex metabolic dysfunction. One major problem in finding therapeutic targets is the fact that the cellular disorders responsible for the development of diabetes involve phylogenetically ancient repair mechanisms. This is one of the reasons why therapeutic targeting of these mechanisms is difficult with the exception of life-style interventions which are, however, limited by individual compliance. In addition, the impact of many therapeutic agents on the entire organism is not well understood. Blood glucose control cannot be considered "high tech" medicine and requires non-medical personnel to reach defined blood glucose targets. Non-adherence to treatment and life-style changes, however, facilitate the interaction of patients and medical personnel and individuals with diabetes are therefore often considered themselves to "blame" for being affected by diabetes. Finally, generating treatment guidelines is extremely difficult as clinical studies targeting vascular endpoints need more than 10 years to become informative, partly due to the so-called glycaemic memory.
Insights
Type 2 diabetes is a growing health burden. Understanding its complex pathophysiology and ancient cellular repair mechanisms is key to developing effective treatments beyond lifestyle changes, which face compliance issues.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Pathophysiology
Background:
- Type 2 diabetes and impaired glucose tolerance present a significant and increasing global health challenge.
- The underlying pathophysiology and long-term complications of diabetes are not fully understood, with hyperglycemia being a late indicator of complex metabolic dysfunction.
- Targeting cellular disorders in diabetes is difficult due to their roots in ancient repair mechanisms, complicating therapeutic development.
Purpose of the Study:
- To explore the challenges in understanding diabetes pathophysiology.
- To identify barriers to effective therapeutic targeting.
- To discuss the difficulties in developing treatment guidelines and the impact of glycaemic memory.
Main Methods:
- Review of current understanding of diabetes pathophysiology.
- Analysis of challenges in therapeutic target identification.
- Discussion of limitations of lifestyle interventions and adherence issues.
- Examination of the prolonged timelines for clinical studies due to glycaemic memory.
Main Results:
- Diabetes pathophysiology involves ancient cellular repair mechanisms, making therapeutic targeting complex.
- Lifestyle interventions are limited by patient compliance.
- The impact of many diabetes therapies on the whole organism is not well understood.
- Clinical studies for vascular endpoints require over a decade of data due to glycaemic memory.
Conclusions:
- Developing effective diabetes treatments requires a deeper understanding of its complex pathophysiology.
- Overcoming challenges related to cellular mechanisms, patient adherence, and study durations is crucial for advancing diabetes care.
- Current approaches face limitations, necessitating innovative strategies for therapeutic development and guideline generation.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
